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Abstract.  This study was undertaken to determine the 
roles of individual a//3,  integrin heterodimers in 
promoting cellular interactions with the different 
attachment-promoting domains of laminin (LN).  To do 
this, antibodies to the integrin ~]  subunit or to specific 
integrin c~ subunits were tested for effects on cell at- 
tachment to LN, to elastase fragments El-4 and El, de- 
rived from the short arms and core of LN's cruciform 
structure, and to fragment E8 derived from the long 
arm of this structure. The human JAR choriocarci- 
noma cells used in this study attached to LN and to 
fragments E1  and E8.  Attachment to El-4 required a 
much higher substrate coating concentration, suggest- 
ing that it is a  poor substrate for JAR cell attachment. 
The ability of cells to attach to different LN domains 
suggested the presence of more than one LN receptor. 
These multiple LN receptors  were shown to be ~ 
integrin heterodimers because antibodies to the inte- 
grin/3,  subunit inhibited attachment of JAR cells to 
LN and its three fragments. To identify the individual 
integrin ot/~]  heterodimers that mediate interactions 
with these LN domains, mAbs specific for individual 
~  heterodimers in human cells were used to study 
JAR cell interactions with LN and its fragments. An 
anti-c~6//3rspecific mAb,  GoH3, virtually eliminated 
cell attachment to E8 and partially inhibited attach- 
ment to E1  and intact LN.  Thus the major ot6//3t 
attachment domain is present in fragment E8.  An a,/ 
/3,-specific mAb ($2G3)  strongly inhibited cell attach- 
ment to collagen IV and partially inhibited JAR 
attachment to LN fragment El.  Thus, the ot~/~, hetero- 
dimer is a  dual receptor for collagen IV and LN, 
interacting with LN at a  site in fragment El.  In com- 
bination, the anti-at and anti-~6-specific antibodies 
completely inhibited JAR cell attachment to LN and 
fragment El.  Thus, the ot~/~3, and ol6/~, integrin het- 
erodimers each function as LN receptors and act to- 
gether to mediate the interactions of human JAR 
choriocarcinoma cells with LN. 
T 
HE basement membrane glycoprotein laminin (LN)' 
is  a  large  (M,  850  kD)  cruciform-shaped complex 
assembled from three different subunits (A, B1, and 
B2), which interacts with many diverse cell types (reviewed 
in Martin and Timpl, 1987).  At least three proteolytic frag- 
ments of LN, El, El-4, and E8, have been shown to interact 
with cells in vitro (see Fig.  1). One of these, E8, which has 
an Mr of 280 kD (Paulsson et al.,  1985) and contains most 
of the long arm of LN, including the heparin-binding frag- 
ment E3, has been shown to promote the attachment of many 
cell types (see Edgar et al.,  1984; Aumailley et al.,  1987; 
Goodman et al.,  1987).  A second large (Mr 630 kD) frag- 
ment, El-4, derived from the short arms and core of LN (Ott 
et al., 1982), promotes the attachment of a distinct, but over- 
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1. Abbreviations  used in this paper:  Col IV, collagen IV;  FN,  fibronec- 
tin; LN, laminin. 
lapping set of cells (Aumailley et al., 1987; Goodman et al., 
1987).  A smaller fragment E1 (Mr 200-260 kD; Ott et al., 
1982), which contains a subset of the domains in El-4, also 
promotes attachment of many cells, including some that do 
not adhere to fragment El-4 and some which interact with 
intact LN only via sites in E8 (see Aumailley et ai.,  1987; 
Goodman et al.,  1987; Nurcombe et al.,  1989). 
The differences between cells in recognition of the multi- 
ple attachment domains of LN are most easily explained by 
the existence of more than one LN receptor. Among receptor 
candidates are the integrins, implicated initially because an- 
tibodies to the  integrin ~,  subunit were  shown to inhibit 
strongly interactions of many cells with LN (see Horwitz et 
al.,  1985; Bozyczko and Horwitz,  1986;  Hall et al.,  1987; 
Tomaselli  et al.,  1987, 1988).  This suggested that heterodi- 
mers containing the integrin/3, subunit and uncharacterized 
ot subunits function as LN receptors. More recently, it has 
been possible to identify four integrin ot subunits that associ- 
ate with the integrin f3, subunit to form LN receptors. One 
of these,  ct3, forms ~3//3, heterodimers that interact with 
©  The Rockefeller University Press, 0021-9525/90/06/2175/10  $2.00 
The Journal  of Cell Biology,  Volume 110, June 1990 2175-2184  2175 several different ECM glycoproteins, including LN (Wayner 
and Carter,  1987; Wayner et al.,  1988; Takada et al.,  1988; 
Gehisen et al., 1988, 1989). The second of these et subunits, 
u6,  appears to form heterodimers that interact specifically 
with LN (Sonnenberg et al.,  1988). A third distinct integrin 
~L  heterodimer  with  an  Mr  200-kD  t~  subunit  has  been 
identified  by  LN  affinity  chromatography  (Ignatius  and 
Reichardt,  1988). An antibody to the c~ subunit of this het- 
erodimer inhibits interactions of rat PC12 pheochromocy- 
toma cells with LN and several collagens, but not fibronectin 
(FN)  (Turner et al.,  1989).  Finally,  an a.~/~  heterodimer 
has been reported to act as a LN receptor in some, but not 
all,  cell types (Elices and Hemler,  1989;  Languino et al., 
1989). 
In this study, the effects of antibodies to specific integrin 
heterodimers on cell interactions of the human choriocarci- 
noma cell line, JAR, with LN fragments were tested to iden- 
tify which  integrin  receptors  mediate  cell  attachment  to 
specific domains of LN. 
Materials and Methods 
Materials 
Costar 96-well fiat-bottom Serocluster plates (no. 3596)  and 6-well plates 
were purchased from Costar Corp. (Cambridge, MA). FN was purchased 
from Collaborative Research (Lexington, MA). Preswollen diethyl amino- 
ethyl cellulose (DE 52)  was purchased from Whatman Biosystems Ltd. 
(Kent, UK). Protein A-Sepharose CL 4B,  heparin Sepharose, and Sepha- 
rose 4B were purchased from Pharmacia Fine Chemicals (Piscataway,  N J). 
[3H]N-Acetyl-~glucosarnine and EnaHance were obtained from New En- 
gland Nuclear (Boston, MA). Ribi Adjuvant was purchased from Ribi Im- 
munochemicals (Hamilton,  MT).  Unless otherwise indicated, all  other 
chemicals, including BSA, and goat anti-rat IgG-agarose were purchased 
from Sigma Chemical Co. (St, Louis, MO). 
Preparation of LN, LN  fragments and 
Polyclonal Antisera 
LN and Col IV were purified from the murine Engelbreth-Holm-Swarm  sar- 
coma by published procedures (Timpl et al., 1979; Kleinman et al., 1982). 
LN purity was assessed by SDS-PAGE. Western blotting with anticollagen 
IV antibodies showed collagen IV to be only a  minor contaminant (not 
shown). The larger fragments of LN, El4 and E8, were prepared from LN 
digested with elastase (E0258, Sigma Chemical Co.) for 4 h at 37°C in 0.05 M 
ammonium  bicarbonate  (enzyme/substrate ratio,  1:100). Digestion  was 
stopped by addition of PMSF and digests were immediately chromato- 
graphed on Bio-Gel A 1.5 m (2.5  x  120 cm) (Bio-Rad Laboratories, Rich- 
mond, CA) in 0.2 M ammonium bicarbonate at 4°C. This effectively sepa- 
rated fragments El-4 and E8 from each other as well as from whole LN 
(Timpl et al.,  1983;  Goodman et al., 1987).  Fragments El-4 and E8 were 
purified further by chromatography on heparin Sepharose: E8  binds to 
heparin Sepharose, whereas El-4 does not (Timpl et al.,  1983).  LN frag- 
ments E1 and E3 were purified from an overnight elastase digest of LN (en- 
zyme/substrate ratio,  1:100) at 37°C as described (Ott et al.,  1982).  Poly- 
clonal antisera to whole LN and to LN fragment E3 were raised in female 
White New Zealand rabbits by standard protocols. IgG was purified from 
rabbit sera by DEAE cellulose chromatography as previously described 
(Hudson and Hay, 1980). Affinity purified rabbit anti-collagen TIV was pur- 
chased from Dr. H. Furthmeyer (Stanford University, Palo Alto, CA). 
LN fragments, summarized in Fig. 1, were identified by biological activ- 
ity, SDS-PAGE profile, reactivity with the anti-E3 antibody and by structure 
as viewed by EM after rotary shadowing. Rotary shadowing was performed 
by dissolving LN and LN fragments in 0.1 M ammonium bicarbonate, 50% 
glycerol, then spraying onto freshly cleaved mica as previously described 
(Shotton et al.,  1979;  Engel et al.,  1981). 
Cells 
JAR choriocarcinoma cells (Patillo,  1971) were cultured in DMEM with 
0.4% glucose, 10% FBS and 50 pg/ml gentamycin. Sp2/0 cells were cul- 
tured in H-Y medium (DME plus 10% NCTC 109,  10% FBS, 50/~g gen- 
tamycin, 0.13 % hypoxanthine, 0.04% thymidine; see Kennett et al., 1980). 
First-trimester human cytotrophoblasts were isolated from 8-12-wk pla- 
centas derived from elective abortions. The cytotrophoblasts were purified 
using sequential coilagenase-hyaluronidase and trypsin treatment of placen- 
tal villi according to Fisher et al. (1989).  Ceils were plated overnight on 
FN-coated 30-ram tissue culture plates in DMEM with 0.4% glucose, 10% 
FBS, and 50 #g/ml gentamycin. Cells were scraped from the wells and 
rinsed twice with serum-free medium before injection into mice. 
Cell Attachment Assay 
Cell attachment to ECM ligands was measured using the assay described 
in Kramer et al. (1989b).  Briefly, wells of 96-well plates were coated over- 
night with purified ECM ligands suspended in PBS at concentrations found 
to be optimal (5-10/~g/ml LN, 5 ~g/ml FN, 0.5-5 ttg/ml Col IV, 2-10/~g/ml 
ES, 100-200 t~g/ml El-4, 1-10 #g/ml El). All wells were blocked with BSA 
for at least 2 h before use (0.2% BSA in PBS). BSA- and poly-D-lysine- 
coated wells served as negative and positive controls, respectively. Ceils 
were harvested with 0.2 % trypsin/2 mM EDTA in calcium-magnesium-free 
PBS (CMF-PBS), washed in serum free DME containing 0.4%  soybean 
trypsin inhibitor and 0.2% BSA. Cells were plated at a density of 2  x  104 
cells in 25 ~1 in wells containing 75/~1 of hybridoma supernatant or purified 
immunoglobulin. After 1 h at 37°C, the plates were shaken on a Labline 
orbital shaker at 350 rpm for intervals sufficient to remove the cells from 
the BSA coated wells (10--30 s). Attached cells were fixed with 2% glutar- 
aldehyde and photographed. Attachment levels were quantified either by 
cell counting or by quantifying trypan blue dye adsorption at OD690, as 
previously described (Hall et al.,  1987). 
mAbs to Human Integrins 
A Lewis rat was given two intraperitoneal injections 2 wk apart with 107 
EDTA-harvested JAR choriocarcinoma cells, mixed 1:I with Ribi adjuvant. 
2 wk later, two additional intrasplenic injections were given 2 wk apart in 
the absence of adjuvant.  A  Balb/c mouse was given four bimonthly in- 
traperitoneal injections of 5 x  106 first-trimester human cytotrophoblasts. 
4 d after the last injection, each spleen was fused with Sp2/0 mouse plas- 
rnacytoma cells by the method of Kennett et al.  (1980),  as modified by 
Wheelock et al. (1987).  Hybridoma supernatants were screened for their 
ability to inhibit JAR human choriocarcinoma cell attachment to FN, LN, 
or Col IV using the attachment assay described above. Two rat hybridoma 
supernatants were found that inhibited attachment to FN only (BIE5 and 
BIIG2), whereas two others inhibited attachment to LN, FN, and Col IV 
(AIIB2 and BIEll). One mouse hybridoma supernatant inhibited attach- 
ment of JAR cells to Col IV only ($2G3). These hybridomas were cloned 
by limiting dilution. The rat antibodies were purified from culture superna- 
tants by affinity chromatography using goat anti-rat agarose. The mouse su- 
pernatant, $2G3,  an IgM, was concentrated 10-fold by precipitation with 
50%  saturated ammonium sulfate at 4°C. These antibodies were retested 
for attachment inhibitory activity on FN, LN and Col IV coated substrates 
before further use. The BIE5 rat mAb, which inhibits attachment to FN, 
LN, and Col IV; and $2G3 mouse mAb, which was identified by its inhibi- 
tion of cell attachment to Col IV, were used in experiments reported here 
(Fig. 4). 
The GoH3  mAb against the a6  chain of the integrin /~t  family,  was 
raised and characterized as described (Sonnenberg et al., 1986,  1988).  An 
mAb against the ott chain of the/~l family, TS2/7,  was the kind gift of Dr. 
Martin Hemler (Dana Farber Cancer Institute, Boston, MA; Hemler et al., 
1984).  mAbs P1H5 and P1B5 that recognize ct2 and or3 subunits of the ~l 
family were kind gifts of Drs. Elizabeth Wayner and William Carter (Fred 
Hutchison Cancer Center, Seattle; Wayner and Carter,  1987). 
Immunoprecipitation 
Attachment-inhibiting antibodies were characterized further by immunopre- 
cipitation as follows. Cells were labeled with [3H]N-acetyl-D-glucosamine 
(50 ttCi/ml) over a 24-h period in low-glucose (0.1%),  serum-containing 
DME. Cells were harvested with 2 mM EDTA in CMF-PBS-BSA, washed 
and lysed in 1 ml/107 cells of lysis buffer (10 mM Tris acetate buffer,  pH 
8.0 containing 0.5% NP-40, 100 mM NaCI, and 1 mM PMSF). Insoluble 
material was removed by centrifugation at 12,000 g for 10 min. Each ml 
of supernatant was precleared by two sequential 1-h incubations with 100 
ttl packed, unconjugated Sepharose 4B beads. Aliquots of 250 pl extract 
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Figure  1.  Laminin diagram. 
Diagram of intact LN delineat- 
ing the location of the cell at- 
tachment domains discussed 
in this study. 
were mixed two parts extract to one part mAb-containing or Sp2/0 superna- 
rant.  Immunoprecipitation  was carried  out as described  in Kramer et al. 
(1989). Samples were  fractionated  by SDS-PAGE (Laernmli,  1970) and 
visualized by fluorography (Bonner and Laskey, 1974). 
For sequential  immunoprecipitations  of extracts by  the anti-s: mAb 
TS2/7, followed by $2G3 and AIIB2 mAbs, the precleared extract was in- 
cubated with anti-eq followed by two sets of goat anti-mouse beads. This 
cycle  was  repeated  twice.  The  last  round  included  three  sets  of goat 
anti-mouse beads to remove completely any remaining primary antibody. 
The depleted  extract was then incubated with $2G3 or AIIB2 mAb and 
precipitated with goat anti-mouse IgG or goat anti-rat IgG beads. All sam- 
ples were washed, eluted and analyzed by SDS-PAGE and fluorography as 
described above. 
Results 
I. Characterization of anti-~ l  lntegrin mAbs (Table I) 
An mAb to the human integrin/3, subunit (AIIB2) was iso- 
lated and used to identify/3, integrins on JAR cells. Several 
experiments indicated that this mAb recognized the/3, sub- 
unit. First, SDS-PAGE analysis of immunoprecipitates of la- 
beled JAR cell extracts showed that this antibody immuno- 
precipitated  several  integrin  subunits.  When  analyzed in 
nonreducing conditions, broad bands of 110-120  and 145- 
150 kD and a sharper band at 190 kD were present. When 
analyzed under reducing conditions, two bands were evident 
at  135-145  kD and 190 kD (Fig. 2, lanes A and E).  This 
differential behavior on reduced and nonreduced gels is diag- 
nostic of the integrin family of adhesion receptors (Knudsen 
et al., 1985; Giancotti et al., 1985; Pytela et al., 1986). Sec- 
ond, the antibody inhibited cell attachment to FN, Col IV 
and intact LN (Fig. 3), but not to vitronectin (not shown). 
This is a specificity similar to that exhibited by the antiavian 
integrin /3t  subunit-specific mAb,  CSAT  (Horwitz et al., 
1985; Bozyczko and Horwitz, 1986; Hall et al., 1987; Neu- 
gebauer and Reichardt,  unpublished experiments).  These 
results indicate that the AIIB2 mAb binds the integrin/3~ 
subunit. This mAb is referred to subsequently as anti-/3t. 
To study the role of individual members of the/31 integrin 
family in the attachment of the JAR human choriocarcinoma 
cell line to LN, attachment-inhibitory mAbs, raised against 
human  choriocarcinoma  and  cytotrophoblast  cells,  were 
used.  The mAbs were selected for their ability to disrupt 
celI-ECM protein interactions and were characterized fur- 
ther to determine their integrin heterodimer specificity. Two 
of the antibodies isolated in this way were used for the present 
study: BIE5, specific for the FN receptor, ot~//3t, and $2G3, 
specific for cr://3], a receptor for both LN and Col IV. 
The BIE5 antibody appears to interact only with the FN- 
binding heterodimer ct5//3~. First, B1E5 inhibited JAR cell 
attachment to FN, but not to LN or Col IV (Fig. 3). It recog- 
nized two bands of 110-120 and 140-150 kD when analyzed 
by immunoprecipitation and SDS-PAGE under nonreducing 
conditions and a single band at 135-145  kD when analyzed 
under reducing conditions (Fig. 2, lanes C and F). Thus, the 
antibody appears to recognize only one heterodimer. This 
must be the ~5//3t heterodimer as this antibody recognizes a 
heterodimer with similar relative molecular mass subunits in 
the K562 cell line which expresses a~/13~, but no other/3z- 
containing  integrins  (Hemler,  M.,  personal  communica- 
tion). This mAb is referred to henceforth as anti-as//3~. 
The $2G3  mAb recognizes the integrin c~//31 heterodi- 
Table I.  Antibodies  Used in the Present Study 
Antibody/  Alternative  Inhibits 
(*NR Ag Mr)  Antigen used/Made in  names  attachment to 
Anti-/3~  JAR cells/Rat mAb  AIIB2$  FN, LN,  Collagen 
(110 kD) 
Anti-oq//3:  $2G3'  Col,  LN fragment 
(190/110  kD)  E1 
Anti-t~j//3~  Ts2/7,§  No activity 
(190/110  kD)  anti-VLA1 
Anti-otJ/31  P 1H5,[I  Col 
(150/110  kD)  anti-VLA2 
Anti-~J/31  P1B5,rl  FN, LN, Collagen 
(150/110  kD)  anti-VLA3 
Anti-t~5//3~  B 1E5*  FN 
(150/110  kD) 
Anti-c~6//31  LN, LN fragments 
(135/110  kD)  E8,  E1 
Cytotrophoblasts 
Mouse n-tAb 
T cells/Mouse mAb 
WI-38 human fibroblasts/ 
Mouse mAb 
WI-38 human fibroblasts/ 
Mouse mAb 
Jar cells/Rat mAb 
Mammary tumor cells/ 
Rat mAb 
GoH31 
anti-VLA6 
* Mr of antigen analyzed by SDS-PAGE  under nonreducing  conditions. 
$ Reported first in this study. 
§ Hemler et al.  (1984), Takada et al. (1987). 
fl Wayner and Carter (1987), Wayner et al. (1988). 
I Sonnenberg et al.  (1986, 1988). 
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raised against members of the fll family of integrins. Extracts of 
[3H]N-acetyl-D-glucosamine-labeled JAR cells  were precipitated 
with mAbs and analyzed on 7.5 % SDS-polyacrylamide gels under 
nonreducing  (lanes A-D)  or  reducing  (lanes E-G)  conditions. 
Lanes A and E:  anti-~  mAb (AIIB2); lane B, anti-t~Jfl~ mAb 
($2G3); lanes C and F, anti-c~JB~ mAb (BIE5); lanes D and G, 
anti-c~6/fl~ mAb (GoH3). 
mer. As shown in Fig. 3, the antibody inhibited JAR attach- 
ment to Col IV, had a small inhibitory effect on attachment 
to intact LN, but had no effect on attachment to FN. SDS- 
PAGE analysis of immunoprecipitates using $2G3 revealed 
two protein bands migrating with Mrs of 110-120 and  190 
kD under nonreducing conditions (Fig. 2, lane B). The 190- 
kD  band  did not change in  apparent mobility upon elec- 
trophoresis  under  reducing  conditions  (compare  190-kD 
band in Fig. 2, lanes A and B with lane E). The protein bands 
recognized by the $2G3 mAb also comigrated with proteins 
immunoprecipitated with the anti-VLA 1 mAb, TS2/7, which 
defines  ot~/B~ (Hemler et  al.,  1984,  1987).  Depletion of 
c~t/fl~ heterodimers by three rounds of sequential immuno- 
precipitation of JAR cell extracts with anti-VLA-1 mAb, re- 
moved the two proteins precipitated by the $2G3 mAb, but 
did not deplete the extract of other members of the fll fam- 
ily  precipitated  by  anti-~3t antibody  (Fig.  4).  Thus,  the 
$2G3  antibody recognizes the  integrin et~/fl~ heterodimer 
and will be referred to as anti-~. 
The  or6  subunit-specific  mAb  GoH3,  prepared  using 
mouse mammary tumor cells as an immunogen (Sonnenberg 
Figure 3. Effects of anti-integrin antibodies on JAR cell attachment 
to FN, LN, and Col IV. mAbs, generated using intact human JAR 
choriocarcinoma or primary cytotrophoblast ceils as the immuno- 
gen (Materials and Methods), were selected for their ability to in- 
hibit cell attachment to purified matrix protein substrates. Three 
mAbs generated in this  manner recognized/3~ integrins: anti-fl~ 
(AIIB2; tt),  anti-~s/fl~ (BIE5; m), and anti-c~/B, ($2G3; m) (see 
Table  1 for  a  complete  list of antibodies).  The  anti-ct6 mAb 
(GoH3; D), generated using murine tumor cells as an immunogen, 
recognizes human c~6 integrin. The control mAb BIVF2, gener- 
ated in the same fusion as the anti-B~ mAbs, recognizes a 90-kD 
surface glycoprotein but does not effect cell-substrate interactions. 
Percent cell attachment, relative to positive (BIVF2) and negative 
(BSA) controls, is shown. Results from several experiments were 
pooled, the error bars denote SEM. 
et al.,  1986), also recognizes the a6 subunit in human cells 
(Sonnenberg et al.,  1987;  Hemler et al.,  t988). GoH3 in- 
hibited JAR cell attachment to LN by ,~70%, but did not 
affect attachment to either FN or Col IV (Fig. 3). In immu- 
noprecipitation studies, GoH3 recognized proteins that mi- 
grated with Mrs of 135 and 110-120 kD when analyzed un- 
der nonreducing conditions (Fig. 2, lane D). Under reducing 
conditions, the o~6 subunit migrated slightly faster than the 
~3~ subunit (Fig. 2, lane G). This antibody will be referred 
to as an  ti-o~. 
The mAbs  described above,  as  well as  additional anti- 
bodies  against  the  integrin  t~2//3t and  c~3//31 heterodimers 
OVayner and Carter,  1987) were used in immunoprecipita- 
tion analyses to obtain a more complete picture of  the variety 
of fl~ integrins expressed by JAR cells (see Table I).  Anti- 
c~/[3~, anti-otJfll, anti-c~3/fl,  anti-ot~/fll, anti-c~6, and anti-/3~ 
antibodies  were  used  to  precipitate  equal  volumes  of a 
[3HlN-acetyl-D-glucosamine labeled JAR cell extract (Fig. 
5).  JAR cells expressed all of the integrins recognized by 
these antibodies except o~2//3~, which was  undetectable by 
these procedures.  The levels of a3/13, also appeared to be 
low in these cells. These experiments are not sufficient to de- 
termine the absolute levels of the individual integrin hetero- 
dimers in JAR ceils, because the efficiency with which each 
antibody precipitated its ligand may not have been equal. 
Comparative studies,  however, using extracts from human 
placental fibroblasts showed relatively high levels of expres- 
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mer.  Extracts  of  [3H]N-acetyl-o-glucosamine-labeled JAR  cells 
were precipitated sequentially by anti-a~//~ (anti-VLAl) and either 
$2G3  or  anti-/~  (AIIB2)  mAbs  as  described  in  Materials  and 
Methods  and  analyzed on 7.5%  SDS-polyacrylamide gels under 
nonreducing conditions. A photograph of the fluorograph of the gel 
is shown. Lane A, anti-/~  (AIIB2) mAb precipitation of an unde- 
pleted extract; lane B, anti-c~/13~ ($2G3) mAb precipitation of an 
undepleted extract; lane C, anti-a~/B~ (anti-VLA  1) first precipita- 
tion;  lane D, anti-at/~  (anti-VLA  1), third precipitation;  lane E, 
anti-c~/B~ ($2G3) precipitation of anti-c~/B~ (anti-VLA1) depleted 
extract;  lane F,  anti-/3~ mAb (AIIB2) precipitation  of anti-u~/~] 
(anti-VLAl)/depleted extract. 
sion of o~2/15~ and ot~/l~,  but a  low level of o~6/B~ (not shown). 
Thus,  the antibodies  to tx:/~]  and a3/13~ are capable of pre- 
cipitating  their  respective  antigens  effectively from  whole 
cell  extracts.  Consequently,  the  o~2 and  a3  subunits  appear 
to be expressed at low levels in JAR cells compared with the 
c~,  a~,  and c~ subunits. 
H. Attachment of JAR Cells to LN Fragments Is 
Inhibited by an Anti-J31 Integrin Antibody 
LN fragments El-4, E1 and E8, which have been shown pre- 
viously to support cell adhesion, were prepared as described 
in Materials and Methods (see Fig.  1 for structures).  The at- 
tachment of the human JAR choriocarcinoma cell line to LN 
and  LN fragments was measured using cell attachment as- 
says. JAR cells, a tumor cell line of epithelial origin attached 
to whole LN as well as to fragments El-4, El, and E8. Con- 
Figure 5.  JAR  cells  express  several  members of the  /~  family. 
Equal  aliquots  of an extract of [3H]N-acetyl-D-glucosamine-labeled 
JAR cells were precipitated with the antibodies indicated, and ana- 
lyzed as in Fig.  4. JAR cells express relatively high levels  c~j//~l, 
as/~l and c~6//~l and low levels of c~3//~t, a21~t is not detectable in 
JAR cells under the conditions used.  Identical analysis of human 
placental  fibroblast cell  extracts  shows  relatively high  levels  of 
al/~l, ~2/~1, t~/~j, and c~s//~l and low levels of c~6//31 (not shown), 
indicating that all the antibodies used are capable of precipitating 
their respective antigens under these conditions. 
centration curves (not shown) indicated that maximal attach- 
ment of JAR cells to LN and its fragmen~ occurred as fol- 
lows;  LN,  2  #g/ml;  E8,  1-2  #g/ml;  El,  1-2  #g/ml;  El-4, 
100-200/~g/ml.  Thus,  El-4 is a  much less effective attach- 
ment substrate than whole LN, E1 or E8. Antibodies to frag- 
ment  E3  inhibited  cell  attachment  to  fragment  E8  Com- 
pletely,  and  reduced  slightly  the attachment  to whole LN, 
but did not inhibit cellular interactions with either fragment 
El-4 or E1  (Fig.  6).  These results  suggested that JAR cells 
attach to at least two sites on LN,  one present in fragment 
E8  and  the other  in  fragments El-4 and El. 
To examine the  functions  of/~l  integrin  heterodimers  in 
JAR cell attachment  to LN, JAR cells were plated on LN, 
LN  fragments  El-4,  El,  and  E8,  in  the  presence  of either 
anti-15t  or an irrelevant mAb that binds to JAR cells but has 
no adhesion disrupting  activity (BIVF2).  As shown in Fig. 
7,  anti-fl~  inhibited  JAR  cell  attachment  to  LN and  to  all 
three  fragments.  It had  no effect on attachment  to poly-o- 
lysine  (not  shown). 
These results indicate that the/5~  integrin  family of adhe- 
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JAR cell attachment to E8, but not to 
the El or El-4 fragments of laminin. 
The figure shows photomicrographs 
of JAR choriocarcinoma cells plated 
on LN and LN fragments El-4,  El 
and  E8,  in the  presence  of anti-E3 
antibody (100 #g/ml) or preimmune 
IgG control (100/~g/ml) mAb. Cells 
were treated as for the attachment as- 
say (see Materials and Methods) and 
photographed  after unattached cells 
were removed. Bar, 100 ~m. 
sion receptors plays a dominant role in the JAR cell attach- 
ment to these three attachment-promoting domains of LN. 
IlL Integrin a~/Bl and adl31Heterodimers 
Mediate JAR Cell Attachment to the E1 and E8 
Attachment-promoting Domains of  LN 
To determine the role of individual integrin heterodimers in 
JAR cell binding to LN, the mAbs recognizing individual 
heterodimers were tested for their effects on the attachment 
of JAR cells to LN and to fragments E1  and E8.  El-4 was 
not used in these experiments due to the very high substrate 
coating concentrations required for optimal cell attachment. 
As shown in Fig. 7, antiintegrin t~t//~  blocked JAR cell at- 
tachment  to  E1  by  60-70%,  but  did  not  have  significant 
effects on JAR cell attachment to E8. Antiintegrin at/13t in- 
hibited interaction with whole LN '~20% (Fig. 7). Thus, the 
integrin al/13t receptor recognized by the $2G3 mAb inter- 
acts with sites on the E1 fragment of LN. In contrast, anti- 
a6/~t  antibody  inhibited  JAR cell attachment to  fragment 
E8 by >90 %. This indicates that the principal interaction of 
JAR  cells  with  fragment E8  is  mediated  by  the  integrin 
ct6//St  receptor.  Anti-ct6/~  antibody  also  blocked  attach- 
ment of JAR cells to intact LN and to fragment E1 by ,050 %. 
These results suggest that the integrin OL6//31 heterodimer in- 
teracts with a second distinct site in LN, which is in the E1 
domain.  They also indicate that the principal JAR attach- 
ment site in intact LN is in the E8 fragment. As expected, 
a mAb specifc for integrin ctd/~m, the fibronectin receptor, 
had no inhibitory effects on JAR cell attachment to LN or 
any of its fragments. 
Since the effects of czt//~rspecific  and ot6,/~l-specific mAbs 
on the attachment of JAR cells to fragment E1 were partial, 
a  mixture of the two antibodies was tested.  Results in Fig. 
7 show that such a mixture was more effective in inhibiting 
JAR attachment to intact LN and to fragment E1 than either 
antibody alone. This antibody combination inhibited JAR at- 
tachment to LN by 85 % and to E1  by 92 % (Fig.  7).  This 
same combination of antibodies did not inhibit cell attach- 
ment to FN, nor did anti-a6//3~ antibody enhance the inhibi- 
tory effect of anti-oh/~  antibody alone on cell attachment 
to Col IV.  Finally, the anti-ots/~t  mAb, which recognizes a 
FN receptor, did not enhance the effects of anti-c~l/~ on cell 
attachment to fragment E8 or to LN. This indicates that anti- 
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Substrate 
Figure  7.  Monoclonal  antibodies  recognizing ~//3~,  and  t~6//3~ 
integrins inhibit JAR attachment to LN, El-4, and E8. JAR cho- 
riocarcinoma cell attachment to LN (5 #g/ml), LN fragments El-4 
(140/~g/ml), E8 (5 #g/ml), FN (5 #g/ml), and collagen IV (5 #g/ml) 
was measured in the presence of anti-integrin antibodies singly and 
in combination, as indicated in the figure. Percent cell attachment, 
relative to positive (BIVF2) and negative (BSA) controls, is shown. 
Data from several different experiments were pooled. Error bars 
denote SEM.  =, AIIB2 (/31); m, BIE5 (5//31); D, $2G3 (1//31); [], 
GoH3 (6//31); [], $2G3  +  GoH3; ~, $2G3  +  B1E5. 
bodies specific for closely related integrin heterodimers do 
not have nonspecific cooperative effects. 
Together, the data presented here suggest that there are two 
/3t integrin receptors for LN on JAR cells, ot~//3~ and ~6//3~. 
The  ot~/~  complex  recognizes  a  domain  present  in  E1 
whereas, integrin ott/~t recognizes fragment E8. The obser- 
vation that anti-ot6/~ also partially inhibits JAR cell attach- 
ment to E1 suggests that ott/B~ may also recognize a distinct 
site in  El.  The ability of a  mixture of the two antibodies 
specific for these receptors to almost completely inhibit at- 
tachment of JAR cells to LN  suggests  that integrin tXl//3~ 
and  ot~//3~ heterodimers mediate the major interactions of 
JAR cells with this ECM glycoprotein. 
Discussion 
Results in this paper indicate that LN contains at least two 
distinct cell attachment-promoting domains. Results also in- 
dicate that integrin/3~ subunit-containing heterodimers are 
used by JAR cells as the dominant receptors for interacting 
with these attachment-promoting domains of LN. We pro- 
vide strong evidence that two individual integrin heterodi- 
mers, ot6//3~ and al/13~,  function as receptors for intact LN 
and our data identify the domains on LN with which these 
receptors  interact.  Integrin  ot~/~l  is  shown  to  be  a  dual 
receptor for collagen IV and for intact LN, with which it in- 
teracts in the E1  fragment. Integrin ~6//3~ interacts primar- 
ily with LN using a site in fragment E8; but may also interact 
with a  second site in fragment El. The results suggest that 
the major JAR cell recognition site in intact LN is in the E8 
fragment.  However,  since  anti-ot~//3~ consistently  inhibits 
JAR cell attachment to intact LN by a small amount (20%), 
and  complements the effects of anti-~6  on intact LN,  the 
site(s) in the E1 region recognized by ot~/~  is at least par- 
tially  accessible  in  intact  LN.  Thus,  integrin  t~//3j  and 
a61/3~ heterodimers appear to act in concert to mediate the 
interactions of JAR cells with LN. 
Previous work from several groups has provided evidence 
for attachment-promoting domains in LN fragments E8, El- 
4, and E1 (Edgar et al., 1984; Paulsson et al., 1985; Engvall 
et al.,  1986; Aumailley et al.,  1987; Goodman et al.,  1987; 
Dillner et al.,  1988;  Terranova et al.,  1983;  Timpl et al., 
1983). Results in this paper provide further evidence for the 
existence of multiple cell attachment domains in LN. JAR 
cells were shown to interact with fragment E8, fragment E1 
and, to a lesser extent, El-4, implying that there are at least 
two separate attachment sites in intact LN. 
Antibodies  to  the  integrin  ~t  subunit  have been previ- 
ously shown to inhibit interactions of many cell types to LN 
and  this  has  suggested  strongly  that  integrin  ~3~  subunit- 
containing heterodimers include receptors for LN (see Hor- 
witz et al.,  1985). Results in this paper extend this work by 
showing that an anti-integrin /3t  antibody inhibits  interac- 
tion of human cells to the three attachment-promoting LN 
fragments described above (Fig. 6). This antibody also in- 
hibited cellular interaction with FN and Col IV. Since some 
cell types have been shown to interact only with certain of 
these LN fragments (El-4, E1 and E8) (Edgar et al.,  1984; 
Goodman et al.,  1987;  Aumailley et al.,  1987), it seemed 
likely that there are multiple, distinct/3~  receptors mediat- 
ing cellular interaction with LN. 
Recent work, when combined with results in this paper, 
indicates that four distinct integrin c~ subunits, when com- 
plexed with the integrin/3t subunit, form receptors that bind 
LN. In this paper, we have isolated the mAb $2G3 and have 
provided explicit evidence that it binds the human integrin 
ctl/~ heterodimer (Fig. 4). Using this antibody, it has been 
possible to inhibit cellular interactions with both LN and Col 
IV (Figs. 3 and 7), providing clear evidence that in JAR cells 
the integrin ctt/~t  heterodimer functions as a  receptor for 
both of these ECM glycoproteins. Using fragments of LN, 
we have shown that this heterodimer interacts with LN frag- 
ment E1 (Fig. 7). It seems likely that this is the same site that 
the O/t/~t  heterodimer uses to interact with intact LN, but 
this has not been demonstrated explicitly, and cannot be as- 
sumed, as it has been shown that "cryptic" sites for binding 
of some cell types are exposed by proteolysis (Aumailley et 
al.,  1987).  In  previous  work,  a  rat  integrin  B~  subunit- 
containing heterodimer with an Mr 200-kD ct subunit has 
been  shown  to  exhibit  direct,  divalent  cation-dependent 
binding to LN (Ignatius and Reichardt, 1988). A mAb (3A3) 
that appears to be specific for this integrin c~ subunit in the 
rat inhibits interactions of the rat pheochromocytoma cell 
line, PC12, to LN and to collagens I and IV (Turner et al., 
1989). The size and binding specificity of the integrin het- 
erodimer identified with this antibody suggests strongly that 
this ot subunit is the rat homologue of human integrin c~. 
More recently, Kramer and Marks have shown that VLA-1 
(c~//3~) binds to immobilized collagen I and IV (1989). 
Evidence that  integrin  o~6//3~ heterodimers mediate  cell 
attachment  to  LN has  been  obtained with  an  ot6-specific 
mAb, GoH3, which inhibits platelet attachment to LN, but 
not to FN, collagens I and III, or fibrinogen (Sonnenberg et 
al.,  1988). In the present study, this integrin ot6-specific an- 
tibody inhibited interactions of JAR cells with intact LN by 
'~70%. The same antibody virtually eliminated interactions 
of these cells with LN fragment E8 and strongly reduced in- 
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that the integrin ot6/Bt heterodimer interacts with at least 
two separate sites in LN, one in fragment E8 and one in frag- 
ment El. The partial inhibitory effects of antiintegrin o~6//~1 
on cell attachment to E1 raises the possibility that E1 is con- 
taminated with E8 or a smaller fragment of E8. Though anti- 
E3 antibody did not inhibit JAR cell attachment to fragment 
El, the possibility remains that E1  is contaminated with a 
portion of E8 missing the anti-E3 domain. E8-1ike fragments 
of LN lacking E3 have been purified and shown to have cell 
attachment activity (reviewed in Engel et al., 1990).  If such 
an E8-1ike fragment was contaminating our E1 preparation, 
JAR cell attachment to it would not be inhibited by anti-E3 
antibody. Thus, the failure of the anti-E3 antibody to inhibit 
JAR cell attachment to E1 does not eliminate the possibility 
of  contamination by these smaller E8-1ike fragments. Cell at- 
tachment activity in E8, but not El, however,  is very ther- 
molabile (Goodman et al., 1987).  The E1 preparation used 
in this study retained •60%  of its cell attachment-promoting 
activity after heating and was still subject to inhibition by 
anti-otl and anti-a6 mAbs (data not shown). These results 
suggest strongly that the interactions between our E1 prepa- 
rations and o~t//3~ integrin are not due to contamination by 
E8 or fragments derived from E8.  These results imply as 
well, that ot6//~ recognizes a heat stable site in E1  that is 
distinct from the  site it recognizes in E8.  The  structural 
similarity or physical proximity of  these two sites was not ad- 
dressed specifically in these experiments and the issue of ix6 
interaction with E1 requires further study (see also Sonnen- 
berg,  1990). 
Two and possibly three additional ot subunits, o~2 (Elices 
et al.,  1989;  Languino et al.,  1989),  a3  (Gehlsen et al., 
1988,  1989) and a putative or7 (Kramer et al., 1989a), also 
form heterodimers that interact with LN in at least some 
cells. The mAb P1B5 to the ct3//3~ heterodimer (Wayner and 
Carter, 1987; Wayner et al., 1988) has been shown to inhibit 
attachment of  human HT 1080 fibrosarcoma cells to LN, FN 
and collagens I and VI. In this study, the ot3//3~ subunit is 
expressed at low levels in JAR cells (Fig. 5). The anti-ct3//3~ 
did not affect JAR cell attachment to LN, LN fragments or 
collagen IV when used alone, and did not complement the 
effects  of anti-ct~//3~ or anti-a6 on JAR cell attachment to 
LN and collagen IV (not shown). In other studies, the ot3//3j 
from rat glioma cells has been purified and shown to exhibit 
direct, divalent cation-dependent binding to LN andFN but 
not collagen (Gehlsen et al., 1988), whereas a similar prepa- 
ration  from human MG  63  cells binds  all  three  ligands 
(Gehlsen  et  al.,  1989).  In  assays  measuring binding  of 
purified c¢3/Bl heterodimers to LN, the only anti-LN mAbs 
that inhibited binding, recognize LN epitopes localized to 
the E8 fragment (Gehlsen et al.,  1989),  implying that this 
integrin heterodimer binds exclusively to a domain in the 
long arm of LN. The data in this paper, combined with those 
of Gehlsen et al. (1988, 1989),  therefore, indicate that two 
different/31 heterodimers (O/6/~1 and et3//3~) recognize the E8 
fragment. 
More  recently,  tx2/~t has  been  shown to  act  as  a  LN 
receptor in melanoma cells (Elices, 1989) and in endothelial 
cells (Languino et al.,  1989).  Anti-integrin a2/BI did not 
have an effect on JAR attachment to either LN or Col IV (not 
shown),  again, probably due to the paucity of tx2//3~ (Fig. 5). 
Using the anti-c~t//31 and ct6//31 antibodies in combination, 
it was  possible to demonstrate the cooperative nature of 
receptor-LN interactions. The anti-oj/31 and anti-o~6//31 an- 
tibodies together inhibited almost completely JAR cell inter- 
action with both intact LN and with fragment E1  (Fig. 7). 
The addition of antibodies reactive with other integrin het- 
erodimers did not enhance the inhibitory effect of  either anti- 
ot~//3t or anfi-adl31.  Thus, the integrin otl//3~ and otdl3~ hetero- 
dimers function independently and cooperatively to promote 
JAR cell attachment to LN. 
The combined results from this and other recent reports 
indicate that it is increasingly difficult to make predictions 
about the integrin tx subunit repertoires of cells that interact 
with LN. At least four heterodimers of the/3t family have 
been shown to interact with LN. Several additional factors 
besides the presence of the ot subunit are also likely to affect 
substrate  specificity.  For  example,  in  some cells,  the  or6 
subunit has also been found associated with a novel/~ sub- 
unit,/~4 (Sonnenberg  et al., 1987; Kajiji et al., 1989). Thus, 
differences in/3 subunit associations may modify the ligand 
specificity of o~6-containing heterodimers as is the situation 
with the vitronectin receptor a subunit (Cheresh et al., 1989). 
Additional factors capable in principle of modifying integrin 
function include posttranslational modifications and recep- 
tor interactions with gangliosides, the cytoskeleton and ac- 
cessory proteins (see Horwitz et al.,  1986).  Such mecha- 
nisms may explain cell type-specific differences in the ligand 
recognition properties of a particular integrin heterodimer 
(Gehlsen et al.,  1989;  Languino et al.,  1989). 
The above discussion points to convincing evidence for 
several distinct integrin c~/~t heterodimers that bind to two 
or more attachment sites in LN, but the biological signifi- 
cance of these multiple receptors and attachment sites is not 
yet clear. One possibility is that individual receptors distin- 
guish between the different forms of LN that occur in vivo. 
Variant forms of LN might arise from the differential synthe- 
sis or localization of the LN B1, B2 and A chains, which has 
been observed during development (Cooper and Macqueen, 
1983;  Klein et al.,  1988).  A homologue of the laminin B1 
subunit, named S-laminin, has recently been described and 
shown to have a restricted temporal and anatomical distribu- 
tion (Hunter et al., 1989).  Additional homologues of the A, 
B1, and B2 chains may also exist (e.g., Aratani and Kitawa, 
1988). Each of these may be recognized by only some of the 
existing LN receptors.  In addition,  LN forms complexes 
with many other ECM components, such as entactin, hepa- 
ran sulfate proteoglycans, and collagen IV (reviewed in Mar- 
tin and Timpl,  1987).  Individual LN cell attachment sites 
may be shielded or exposed by these associated molecules. 
Finally, different LN isoforms do appear to have different 
functions. Development of kidney epithelial polarity, for ex- 
ample, has been shown to require expression of the LN A 
chain (Klein et al.,  1988).  Thus, differentiation of specific 
cells may well require function of a specific integrin hetero- 
dimer. 
In conclusion, there is considerable heterogeneity in LN- 
containing structures. This is likely to be the case for other 
large multi  functional ECM ligands as well. Therefore, what 
appears to be a redundancy in integrin receptors may in fact 
be necessary to allow cells to interact with ECM ligands in 
some  environmental contexts but  not  in  others.  Specific 
receptor-ECM interactions may also result in the transmis- 
sion of  distinct signals to the cell interior (Werb et al., 1989). 
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umented in this and other studies may constitute a basis for 
cells to sense and to communicate to the cell interior changes 
in their extracellular environment. 
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